News and Announcements
Revolutionary New Arthritis Treatment from Jardine Pharmaceuticals
- Published April 09, 2015 10:46AM UTC
- Publisher Wholesale Investor
- Categories Company Updates
There is a basic human desire to relieve pain and prolong life, which fuels the search for effective medications. Most drugs come from nature and more than half of the world’s population still rely entirely on plants for their medicines.
Oak is used traditionally for treatment of arthritis. Pharmaceutical efficacy is now achieved through a proprietary extraction process for oak, beating arthritis drugs. The TGA listed oak Polypill™ capsules will be launched through existing distribution networks (Q4 2014).
Jardine Pharmaceuticals has the exclusive worldwide licence for modified polyphenol oak extracts in a complementary medicine format.
Jardine Pharmaceuticals is raising capital to fund further product/market development and research.
Yesterday, Jardine Pharmaceuticals were featured on Current Affair. To watch the video, please click the image below.
Company Updates
Built on discipline, not complexity: inside an ASX equities income strategy
Haydn Froggatt and Zac Brabin have decades of derivatives experience between them and access to almost any strategy in the market. They use two of the simplest structures available, and wrote 202 positions with them last year. Published by Fairway Capital Management. Based on an interview with co-founders Haydn Froggatt and Zac Brabin. Two traders, […]
BlackRock has named the next Economy. What this latest paper means for Private Market Investors.
BlackRock has put a name on something the smart money has been circling for two years. Its digital assets research team calls it the machine-native economy. The thesis fits in one line. AI is machine-native intelligence. Digital assets are machine-native money. Both are built on the same architecture, and they are converging into a single […]
Where’s the beef? Blackstone just answered the AI question.
In 1984, a fast food ad asked a question that became a catchphrase. Where’s the beef? Jon Gray, President of Blackstone, used that line this month in front of global LPs. It is the question every capital allocator is asking about AI. Trillions of dollars are going into chips, data centres and power. That is […]
Backed By Leading Investment Groups and Family Offices
